[vc_row][vc_column][vc_column_text dp_text_size=”size-4″]Professor Richard Scolyer, a prominent Australian physician, celebrates one year of being “cancer-free” following a groundbreaking treatment he devised himself. Last year, at 57, he received a diagnosis of aggressive brain cancer (glioblastoma) while in Poland, a condition with typically low survival rates of just 12 months. Leveraging his expertise in melanoma research, Professor Scolyer chose to undergo an experimental treatment he had developed.
Recent MRI scans showed no signs of the tumor, marking a significant milestone in his recovery journey. Collaborating with his colleague Professor Georgina Long, both co-directors of the Melanoma Institute Australia, Professor Scolyer’s groundbreaking achievements were recognized with the prestigious Australian of the Year award.
Read more: UAE Flights Adopt New protocol Against Infections
Having been the first brain cancer patient to undergo this pre-surgical treatment regimen last year, Professor Scolyer faced post-treatment challenges including seizures, liver issues, and pneumonia. However, he now enjoys improved health and celebrates being “cancer-free” after a year.
Expressing his joy, Professor Scolyer shared, “I’m just thrilled and delighted, couldn’t be happier. I’m the best I have felt for yonks.” While acknowledging the progress made, Professor Long emphasized the need for further research to validate the effectiveness of this treatment approach in a larger population.
Professor Scolyer’s case has sparked optimism in the field of brain cancer treatment. His decision to pursue an innovative immunotherapy treatment, developed in collaboration with Professor Long, shows promising early results. With approximately 300,000 brain cancer diagnoses annually worldwide, this approach has the potential to revolutionize treatment options, although further clinical trials and development are necessary before widespread adoption.
[/vc_column_text][/vc_column][/vc_row]
